However, oncologic patients present a higher predisposition to thrombotic complications due to cancer-related hypercoagulability, the use of central venous catheters, infections, and the prothrombotic effects of certain chemotherapy agents such as L-asparaginase and corticosteroids. This evidence concerns the gene ASPG and thrombophilia.